Individualized dosing of fluoropyrimidine‐based chemotherapy to prevent severe fluoropyrimidine‐related toxicity: what are the options?

JE Knikman, H Gelderblom, JH Beijnen… - Clinical …, 2021 - Wiley Online Library
Fluoropyrimidines are widely used in the treatment of several types of solid tumors. Although
most often well tolerated, severe toxicity is encountered in~ 20–30% of the patients …

Genomics of rare genetic diseases—experiences from India

S Sivasubbu, V Scaria - Human genomics, 2019 - Springer
Home to a culturally heterogeneous population, India is also a melting pot of genetic
diversity. The population architecture characterized by multiple endogamous groups with …

Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health

Y Zhou, VM Lauschke - Human Genetics, 2022 - Springer
Both safety and efficacy of medical treatment can vary depending on the ethnogeographic
background of the patient. One of the reasons underlying this variability is differences in …

Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping

C White, RJ Scott, C Paul, A Ziolkowski… - Clinical …, 2022 - Wiley Online Library
Fluoropyrimidines (FP; 5‐fluorouracil, capecitabine, and tegafur) are a commonly prescribed
class of antimetabolite chemotherapies, used for various solid organ malignancies in over 2 …

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - Taylor & Francis
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

[HTML][HTML] Fluorouracil therapy and DPYD genotype

L Dean, M Kane - 2021 - europepmc.org
Fluorouracil, or 5-flourouracil (5-FU), is a chemotherapy agent that belongs to the drug class
of fluoropyrimidines. When given as an intravenous (IV) solution, 5-FU is used in the …

Population pharmacogenomics for precision public health in Colombia

SD Nagar, AM Moreno, ET Norris, L Rishishwar… - Frontiers in …, 2019 - frontiersin.org
While genomic approaches to precision medicine hold great promise, they remain
prohibitively expensive for developing countries. The precision public health paradigm …

Heterogeneity in the distribution of 159 drug-response related SNPs in world populations and their genetic relatedness

T Ahsan, NJ Urmi, AA Sajib - PLoS One, 2020 - journals.plos.org
Interethnic variability in drug response arises from genetic differences associated with drug
metabolism, action and transport. These genetic variations can affect drug efficacy as well as …

Cancer awareness, diagnosis and treatment needs in Mizoram, India: evidence from 18 years trends (2003–2020)

E Zomawia, Z Zami, A Vanlallawma… - The Lancet Regional …, 2023 - thelancet.com
Background Despite being the second least populated state, Mizoram exhibits the highest
incidence rate of cancer in India. Its inhabitants, constituting an endogamous and isolated …

Challenges and solutions in patient treatment strategies for stage II colon cancer

S Fotheringham, GA Mozolowski… - Gastroenterology …, 2019 - academic.oup.com
Colorectal cancer remains one of the most common cancers worldwide and, despite
improvements in treatment options for late-stage metastatic cancer, there are still questions …